Lv2
146 积分 2021-06-11 加入
Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway
3天前
已完结
The complement system as a potential therapeutic target in rheumatic disease
7天前
已完结
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
20天前
已完结
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
23天前
已完结
科学"望远":近视防控中的有效手段与常见误区
24天前
已完结
Promise and challenges for direct small molecule AMPK activators
1个月前
已完结
New insights into activation and function of the AMPK
1个月前
已完结
Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK)
1个月前
已完结
Hit-to-Lead Optimization and Discovery of 5-((5-([1,1′-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903)
1个月前
已完结
皖公网安备34019202002308
